Categories : Oncology
Product Packaging : 30 in HDPE
Product Composition : 200mg
Send MessageSorafenib tablets are targeted oncology medicines classified as multikinase inhibitors, primarily used in the treatment of hepatocellular carcinoma (liver cancer), renal cell carcinoma, and differentiated thyroid cancer. The formulation works by inhibiting multiple intracellular and cell surface kinases involved in tumor growth and angiogenesis, helping to slow cancer progression.
In international pharmaceutical markets, Sorafenib tablets exporter India and liver cancer medicine supplier India are widely searched by oncology distributors and specialty drug importers. Genliva Wellness LLP, Himatnagar, operates as a pharma exporter India multikinase inhibitor medicines partner, supplying high-demand targeted therapies to global healthcare providers and pharmaceutical companies.
Sorafenib tablets are formulated as a multi-kinase inhibitor that interferes with tumor cell signaling and angiogenesis. The formulation is designed to limit cancer progression by targeting pathways responsible for cell proliferation and blood vessel formation.
This medication is used in the management of specific advanced cancers where inhibition of tumor growth and vascular supply is required.
The formulation offers a multi-pathway therapeutic approach, enabling broader control over tumor development and spread. It supports structured oncology treatment strategies.
